Preventing and controlling influenza virus infection remains a global public health
challenge, as it causes seasonal epidemics to unexpected pandemics. These infections are …

Influenza outbreaks cause pandemics in millions of people. The treatment of influenza
remains a challenge due to significant genetic polymorphism in the influenza virus. Also …

The evolution of drug-resistant viral strains following natural acquisition of resistance
mutations is a major obstacle to antiviral therapy. Besides the improper prescription of the …

Dual oxidase 1 (DUOX1) is an NADPH oxidase that is highly expre-ssed in respiratory
epithelial cells and produces H2O2 in the airway lumen. While a line of prior in vitro …

Influenza A virus (IAV) exploits host metabolic pathways to support its replication. To
improve the understanding of lipid metabolic changes that could occur upon IAV infection, a …

Influenza virus infection, more commonly known as the 'cold flu', is an etiological agent that
gives rise to recurrent annual flu and many pandemics. Dated back to the 1918-Spanish Flu …

Ethnopharmacological relevance Apiaceae plants possess various pharmacological
properties, such as antimicrobial, antioxidant, hypoglycemic, hypolipidemic, anxiolytic …

Neuraminidase (NA) is an important surface protein on influenza virions, playing an
essential role in the viral life cycle and being a key target of the immune system. Despite the …

Severe viral pneumonia is a significant cause of morbidity and mortality globally, whether
due to outbreaks of endemic viruses, periodic viral epidemics, or the rarer but devastating …

The use of vaccinations and antiviral medications have gained popularity in the therapeutic
management of avian influenza H7N9 virus lately. Antiviral medicines are more popular due …